# N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults

> **NCT01962961** · PHASE1,PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 24 (actual)

## Conditions studied

- HIV
- Endothelial Dysfunction
- Oxidative Stress

## Interventions

- **DIETARY_SUPPLEMENT:** PharmaNAC (N-acetylcysteine)
- **DIETARY_SUPPLEMENT:** Matching placebo

## Key facts

- **NCT ID:** NCT01962961
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-06
- **Final completion:** 2015-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01962961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01962961, "N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01962961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*